197 related articles for article (PubMed ID: 35940828)
1. Is in-utero exposure to cannabis associated with the risk of attention deficit with or without hyperactivity disorder? A cohort study within the Quebec Pregnancy Cohort.
Tchuente V; Sheehy O; Zhao JP; Gorgui J; Gomez YH; Berard A
BMJ Open; 2022 Aug; 12(8):e052220. PubMed ID: 35940828
[TBL] [Abstract][Full Text] [Related]
2. Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring.
Christensen J; Pedersen L; Sun Y; Dreier JW; Brikell I; Dalsgaard S
JAMA Netw Open; 2019 Jan; 2(1):e186606. PubMed ID: 30646190
[TBL] [Abstract][Full Text] [Related]
3. Association of Timing and Duration of Prenatal Analgesic Opioid Exposure With Attention-Deficit/Hyperactivity Disorder in Children.
Trønnes JN; Lupattelli A; Handal M; Skurtveit S; Ystrom E; Nordeng H
JAMA Netw Open; 2021 Sep; 4(9):e2124324. PubMed ID: 34524436
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and determinants of attention deficit/hyperactivity disorder (ADHD) medication use during pregnancy: Results from the Quebec Pregnancy/Children Cohort.
Lemelin M; Boukhris T; Zhao JP; Sheehy O; Bérard A
Pharmacol Res Perspect; 2021 May; 9(3):e00781. PubMed ID: 34003597
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant Use in Pregnancy and the Risk of Attention Deficit with or without Hyperactivity Disorder in Children.
Boukhris T; Sheehy O; Bérard A
Paediatr Perinat Epidemiol; 2017 Jul; 31(4):363-373. PubMed ID: 28640459
[TBL] [Abstract][Full Text] [Related]
6. Maternal ADHD medication use during pregnancy and the risk of ADHD in children: Importance of genetic predispositions and impact of using a sibling analysis.
Lemelin M; Sheehy O; Zhao JP; Bérard A
Eur Neuropsychopharmacol; 2021 Mar; 44():66-78. PubMed ID: 33461830
[TBL] [Abstract][Full Text] [Related]
7. Methylparaben in meconium and risk of maternal thyroid dysfunction, adverse birth outcomes, and Attention-Deficit Hyperactivity Disorder (ADHD).
Baker BH; Wu H; Laue HE; Boivin A; Gillet V; Langlois MF; Bellenger JP; Baccarelli AA; Takser L
Environ Int; 2020 Jun; 139():105716. PubMed ID: 32283359
[TBL] [Abstract][Full Text] [Related]
8. Prescription Stimulant Use During Pregnancy and Risk of Neurodevelopmental Disorders in Children.
Suarez EA; Bateman BT; Hernandez-Diaz S; Straub L; McDougle CJ; Wisner KL; Gray KJ; Pennell PB; Lester B; Zhu Y; Mogun H; Huybrechts KF
JAMA Psychiatry; 2024 May; 81(5):477-488. PubMed ID: 38265792
[TBL] [Abstract][Full Text] [Related]
9. Association of Prenatal Exposure to Benzodiazepines and Z-Hypnotics With Risk of Attention-Deficit/Hyperactivity Disorder in Childhood.
Sundbakk LM; Gran JM; Wood ME; Handal M; Skurtveit S; Nordeng H
JAMA Netw Open; 2022 Dec; 5(12):e2246889. PubMed ID: 36520439
[TBL] [Abstract][Full Text] [Related]
10. Individual and Combined Association Between Prenatal Polysubstance Exposure and Childhood Risk of Attention-Deficit/Hyperactivity Disorder.
Garrison-Desany HM; Hong X; Maher BS; Beaty TH; Wang G; Pearson C; Liang L; Wang X; Ladd-Acosta C
JAMA Netw Open; 2022 Mar; 5(3):e221957. PubMed ID: 35275164
[TBL] [Abstract][Full Text] [Related]
11. Association of Maternal Autoimmune Disease With Attention-Deficit/Hyperactivity Disorder in Children.
Nielsen TC; Nassar N; Shand AW; Jones H; Guastella AJ; Dale RC; Lain SJ
JAMA Pediatr; 2021 Mar; 175(3):e205487. PubMed ID: 33464287
[TBL] [Abstract][Full Text] [Related]
12. Association Between Maternal Exposure to Magnetic Field Nonionizing Radiation During Pregnancy and Risk of Attention-Deficit/Hyperactivity Disorder in Offspring in a Longitudinal Birth Cohort.
Li DK; Chen H; Ferber JR; Hirst AK; Odouli R
JAMA Netw Open; 2020 Mar; 3(3):e201417. PubMed ID: 32207831
[TBL] [Abstract][Full Text] [Related]
13. Association of Prenatal Acetaminophen Exposure Measured in Meconium With Risk of Attention-Deficit/Hyperactivity Disorder Mediated by Frontoparietal Network Brain Connectivity.
Baker BH; Lugo-Candelas C; Wu H; Laue HE; Boivin A; Gillet V; Aw N; Rahman T; Lepage JF; Whittingstall K; Bellenger JP; Posner J; Takser L; Baccarelli AA
JAMA Pediatr; 2020 Nov; 174(11):1073-1081. PubMed ID: 32986124
[TBL] [Abstract][Full Text] [Related]
14. Association of Maternal Use of Triptans During Pregnancy With Risk of Attention-Deficit/Hyperactivity Disorder in Offspring.
Harris GM; Wood M; Ystrom E; Nordeng H
JAMA Netw Open; 2022 Jun; 5(6):e2215333. PubMed ID: 35657626
[TBL] [Abstract][Full Text] [Related]
15. Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age.
Wang Z; Chan AYL; Coghill D; Ip P; Lau WCY; Simonoff E; Brauer R; Wei L; Wong ICK; Man KKC
JAMA Intern Med; 2021 Oct; 181(10):1332-1340. PubMed ID: 34398171
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study.
Hálfdánarson Ó; Cohen JM; Karlstad Ø; Cesta CE; Bjørk MH; Håberg SE; Einarsdóttir K; Furu K; Gissler M; Hjellvik V; Kieler H; Leinonen MK; Nørgaard M; Öztürk Essen B; Ulrichsen SP; Reutfors J; Zoega H
Evid Based Ment Health; 2022 May; 25(2):54-62. PubMed ID: 34810174
[TBL] [Abstract][Full Text] [Related]
17. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders.
Liew Z; Ritz B; Rebordosa C; Lee PC; Olsen J
JAMA Pediatr; 2014 Apr; 168(4):313-20. PubMed ID: 24566677
[TBL] [Abstract][Full Text] [Related]
18. In utero exposure to β-2-adrenergic receptor agonist and attention-deficit/hyperactivity disorder in children.
Liang H; Chen J; Miao M; Christensen J; Dalsgaard S; Yuan W; Li J
Eur Child Adolesc Psychiatry; 2017 Jul; 26(7):847-856. PubMed ID: 28185095
[TBL] [Abstract][Full Text] [Related]
19. Prenatal cannabis use and the risk of attention deficit hyperactivity disorder and autism spectrum disorder in offspring: A systematic review and meta-analysis.
Tadesse AW; Dachew BA; Ayano G; Betts K; Alati R
J Psychiatr Res; 2024 Mar; 171():142-151. PubMed ID: 38281464
[TBL] [Abstract][Full Text] [Related]
20. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study.
Lupattelli A; Mahic M; Handal M; Ystrom E; Reichborn-Kjennerud T; Nordeng H
BJOG; 2021 Nov; 128(12):1917-1927. PubMed ID: 33982858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
